Our finding that Th1 IFNγ+ cells are also increased in the ILN of hESC-MSC-treated mice is consistent with the protective role of IFNγ in CIA [35–37] and some reports of therapeutic use of recombinant IFNγ in human RA [38, 39]. Here, IFNG is linked to rheumatoid arthritis.